Phosphatidyl-2′,3′-dideoxy-3′-thiacytidine: synthesis and antiviral activity in hepatitis B- and HIV-1-infected cells

This publication has 16 references indexed in Scilit:

• Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice
  Antiviral Research, 1994
• Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2',3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) and related compounds
  The Journal of Organic Chemistry, 1992
• Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication
  Antiviral Research, 1992
• (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro
  Antimicrobial Agents and Chemotherapy, 1992
• In situ complexation directs the stereochemistry of N-glycosylation in the synthesis of thialanyl and dioxolanyl nucleoside analogs
  Journal of the American Chemical Society, 1991
• Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog
  Antimicrobial Agents and Chemotherapy, 1991
• Metabolism, Toxicity, and Anti‐HIV Activity of 2′‐Deoxy‐3′‐Thia‐Cytidine (BCH‐189) in T and B Cell Lines
  Annals of the New York Academy of Sciences, 1990
• Characterization of Reverse Transcriptase Activity and Susceptibility to Other Nucleosides of AZT‐Resistant Variants of HIV‐1
  Annals of the New York Academy of Sciences, 1990
• HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
  Science, 1989
• Characterization of Serum Netralization Response to the Human Immunodeficiency Virus (HIV)
  AIDS Research and Human Retroviruses, 1987